Mckenna Garvey, LCSW - Medicare Clinical Social Worker in Appleton, WI

Mckenna Garvey, LCSW is a medicare enrolled "Social Worker - Clinical" provider in Appleton, Wisconsin. She graduated from medical school in 2019 and has 5 years of diverse experience with area of expertise as Clinical Social Worker. She is a member of the group practice Us 2 Behavioral Health Care Inc. and her current practice location is 119 N Mccarthy Rd Ste P, Appleton, Wisconsin. You can reach out to her office (for appointments etc.) via phone at (920) 903-1060.

Mckenna Garvey is licensed to practice in Wisconsin (license number 9818-123) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1508484833.

Contact Information

Mckenna Garvey, LCSW
119 N Mccarthy Rd Ste P,
Appleton, WI 54913-9112
(920) 903-1060
(920) 903-1164



Healthcare Provider's Profile

Full NameMckenna Garvey
GenderFemale
SpecialityClinical Social Worker
Experience5 Years
Location119 N Mccarthy Rd Ste P, Appleton, Wisconsin
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Mckenna Garvey graduated from medical school in 2019
  NPI Data:
  • NPI Number: 1508484833
  • Provider Enumeration Date: 07/13/2020
  • Last Update Date: 11/23/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 7911398144
  • Enrollment ID: I20211227000155

Medical Identifiers

Medical identifiers for Mckenna Garvey such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1508484833NPI-NPPES
100101583MedicaidWI

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
1041C0700XSocial Worker - Clinical 131862-121 (Wisconsin)Secondary
1041C0700XSocial Worker - Clinical 9818-123 (Wisconsin)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Us 2 Behavioral Health Care Inc.15576911517

News Archive

FDA advisory committee postpones Panel review of Gen-Probe's PROGENSA PCA3 Assay

DiagnoCure, Inc., a life sciences company that develops and commercializes high‐value cancer diagnostic tests, announced today that Gen-Probe Incorporated, its commercial partner for the PCA3 test, received notice from the U.S. Food and Drug Administration (FDA) that the PROGENSA PCA3 Assay will not be reviewed by the Immunology Panel of FDA's Medical Devices Advisory Committee on October 14, 2011 as previously scheduled, but will be reviewed by the Panel at a later date.

In the wake of the latest SARS outbreak CDC has implemented new system to guide travelers about potential health hazards

The Centers for Disease Control and Prevention (CDC) today implemented a new system for providing travelers with guidance about potential health hazards and the steps they can take to protect themselves when traveling abroad. The new system makes it easier for the public to understand what their risks may be during an emerging public health crisis and what they can do to protect themselves.

Cephalon acquires Mepha

Cephalon, Inc. announced that it has today completed its previously announced acquisition of Mepha, the Swiss-based pharmaceutical company. As a result of the acquisition, Mepha is now a wholly-owned subsidiary of Cephalon. The purchase price paid at closing, inclusive of certain closing adjustments, was CHF 662.4 million (or approximately US$615.4 million). The purchase price is also subject to further post-closing working capital and net debt adjustments.

Study reassures the safety, immunogenicity of COVID-19 vaccines for patients with rheumatic diseases

New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that the COVID-19 vaccine was not associated with severe disease flares in patients with rheumatic diseases.

Antibiotic Resistance Threats report highlights significant gaps and impact of federal investments

The Antibiotic Resistance Threats Report released by the U.S. Centers for Disease Prevention and Control today shows that while recent federal investments to combat antibiotic resistance have had meaningful impacts, the continued spread of infections that are not effectively treated by existing medicines pose deadly threats to patients and public health.

Read more Medical News

› Verified 9 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Mckenna Garvey allows following entities to bill medicare on her behalf.
Entity NameUs 2 Behavioral Health Care Inc.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1083268635
PECOS PAC ID: 1557691151
Enrollment ID: O20191024000284

News Archive

FDA advisory committee postpones Panel review of Gen-Probe's PROGENSA PCA3 Assay

DiagnoCure, Inc., a life sciences company that develops and commercializes high‐value cancer diagnostic tests, announced today that Gen-Probe Incorporated, its commercial partner for the PCA3 test, received notice from the U.S. Food and Drug Administration (FDA) that the PROGENSA PCA3 Assay will not be reviewed by the Immunology Panel of FDA's Medical Devices Advisory Committee on October 14, 2011 as previously scheduled, but will be reviewed by the Panel at a later date.

In the wake of the latest SARS outbreak CDC has implemented new system to guide travelers about potential health hazards

The Centers for Disease Control and Prevention (CDC) today implemented a new system for providing travelers with guidance about potential health hazards and the steps they can take to protect themselves when traveling abroad. The new system makes it easier for the public to understand what their risks may be during an emerging public health crisis and what they can do to protect themselves.

Cephalon acquires Mepha

Cephalon, Inc. announced that it has today completed its previously announced acquisition of Mepha, the Swiss-based pharmaceutical company. As a result of the acquisition, Mepha is now a wholly-owned subsidiary of Cephalon. The purchase price paid at closing, inclusive of certain closing adjustments, was CHF 662.4 million (or approximately US$615.4 million). The purchase price is also subject to further post-closing working capital and net debt adjustments.

Study reassures the safety, immunogenicity of COVID-19 vaccines for patients with rheumatic diseases

New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that the COVID-19 vaccine was not associated with severe disease flares in patients with rheumatic diseases.

Antibiotic Resistance Threats report highlights significant gaps and impact of federal investments

The Antibiotic Resistance Threats Report released by the U.S. Centers for Disease Prevention and Control today shows that while recent federal investments to combat antibiotic resistance have had meaningful impacts, the continued spread of infections that are not effectively treated by existing medicines pose deadly threats to patients and public health.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mckenna Garvey is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Mckenna Garvey, LCSW
119 N Mccarthy Rd Ste P,
Appleton, WI 54913-9112

Ph: (920) 903-1060
Mckenna Garvey, LCSW
119 N Mccarthy Rd Ste P,
Appleton, WI 54913-9112

Ph: (920) 903-1060

News Archive

FDA advisory committee postpones Panel review of Gen-Probe's PROGENSA PCA3 Assay

DiagnoCure, Inc., a life sciences company that develops and commercializes high‐value cancer diagnostic tests, announced today that Gen-Probe Incorporated, its commercial partner for the PCA3 test, received notice from the U.S. Food and Drug Administration (FDA) that the PROGENSA PCA3 Assay will not be reviewed by the Immunology Panel of FDA's Medical Devices Advisory Committee on October 14, 2011 as previously scheduled, but will be reviewed by the Panel at a later date.

In the wake of the latest SARS outbreak CDC has implemented new system to guide travelers about potential health hazards

The Centers for Disease Control and Prevention (CDC) today implemented a new system for providing travelers with guidance about potential health hazards and the steps they can take to protect themselves when traveling abroad. The new system makes it easier for the public to understand what their risks may be during an emerging public health crisis and what they can do to protect themselves.

Cephalon acquires Mepha

Cephalon, Inc. announced that it has today completed its previously announced acquisition of Mepha, the Swiss-based pharmaceutical company. As a result of the acquisition, Mepha is now a wholly-owned subsidiary of Cephalon. The purchase price paid at closing, inclusive of certain closing adjustments, was CHF 662.4 million (or approximately US$615.4 million). The purchase price is also subject to further post-closing working capital and net debt adjustments.

Study reassures the safety, immunogenicity of COVID-19 vaccines for patients with rheumatic diseases

New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that the COVID-19 vaccine was not associated with severe disease flares in patients with rheumatic diseases.

Antibiotic Resistance Threats report highlights significant gaps and impact of federal investments

The Antibiotic Resistance Threats Report released by the U.S. Centers for Disease Prevention and Control today shows that while recent federal investments to combat antibiotic resistance have had meaningful impacts, the continued spread of infections that are not effectively treated by existing medicines pose deadly threats to patients and public health.

Read more News

› Verified 9 days ago


Social Worker in Appleton, WI

Marissa A Mielke,
Clinical Social Worker
Medicare: Not Enrolled in Medicare
Practice Location: 14 Tri Park Way Bldg 2, Appleton, WI 54914
Phone: 920-809-4125    
Ms. Suzan L. Myhre, MSSW
Clinical Social Worker
Medicare: Not Enrolled in Medicare
Practice Location: 3301 N Ballard Rd Ste C, Appleton, WI 54911
Phone: 920-202-3954    Fax: 920-202-3964
Ms. Michelle Kennedy Coenen, MS
Clinical Social Worker
Medicare: Not Enrolled in Medicare
Practice Location: 1531 S Madison St, Ste 550, Appleton, WI 54915
Phone: 920-738-2700    Fax: 920-738-8051
Mrs. Katherine Anne Chaganos, LCSW
Clinical Social Worker
Medicare: Medicare Enrolled
Practice Location: 320 S Walnut St, Appleton, WI 54911
Phone: 920-832-5270    Fax: 920-832-4767
Ms. Kim S Charniak, LCSW
Clinical Social Worker
Medicare: May Accept Medicare Assignments
Practice Location: 444 N Westhill Blvd, Appleton, WI 54914
Phone: 920-750-7000    Fax: 920-364-2451
Ms. Pakou Thao, APSW
Clinical Social Worker
Medicare: Not Enrolled in Medicare
Practice Location: 119 N Mccarthy Rd Ste P, Appleton, WI 54913
Phone: 920-903-1060    Fax: 920-903-1164
Amie Nicole Towne, LMSW
Clinical Social Worker
Medicare: Medicare Enrolled
Practice Location: 330 W College Ave Ste 303, Appleton, WI 54911
Phone: 617-379-0496    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.